Mechanisms of action of GLP-1RAs

10' education - Oct. 21, 2019 - Prof. Filip Knop, MD - Copenhagen, Denmark

Video navigation menu

The incretin hormone GLP-1 and GLP-1 receptors 01:46
Mechanisms of GLP-1RAs to reduce CV risk 03:30
Effects on glycemia 03:53
Effects on body weight 06:43
Effects on blood pressure 09:12
Effects on blood lipids 10:17

Educational information

This lecture held by prof. Knop was part of an accredited symposium "Transforming diabetes management in cardiology: Impact of novel therapies" held during ESC Congress 2019 in Paris, France.

Faculty

Filip Krag Knop, MD, Professor of endocrinology and Director of Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Denmark.

Disclosures

This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.

Funding

Funding for this educational program was provided by an unrestricted educational grant from Novo Nordisk A/S.

View the slides of this presentation

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.